E093 Real-life switching from infliximab innovator (Remicade) to biosimilar (Inflectra) in patients with various rheumatic diseases: a 6-month single-centre prospective observational study
Rheumatology（2019）
关键词
various rheumatic diseases,infliximab innovator,remicade,inflectra,real-life,single-centre
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要